Schaftoside from galgeuntang as a multi-target class I histone deacetylase inhibitor: Integrated molecular docking, dynamics, and systems pharmacology analysis

Computational Biology and Chemistry · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles